Synthesis of Radiofluorinated PET Imaging Agents

描述（由申请人提供）：组织的非侵入性诊断成像对于确定疾病的识别和分期以及评估治疗方案的疗效至关重要。虽然大多数成像方法提供结构信息（CAT，X射线，MRI），正电子发射断层扫描允许特定的生化活性区域的成像。正电子发射放射性示踪剂可以被设计成定位于特定的组织类型，例如肿瘤，或者它们可以给出正常代谢活性的测量。正电子发射核18F具有理想的半衰期（110分钟）和相对较短的正电子扩散距离（1 mm）;这些特征允许快速获得从[18F]氟化放射性示踪剂获得的相对高分辨率图像，对患者几乎没有残留的放射性危害。不幸的是，许多理想的[18F]氟化物标记的放射性示踪剂的制备受到缺乏高效，广泛适用的芳香族放射性示踪方法的阻碍。本研究的目标是发展一种无载体添加（n.c.a.）的富电子芳环放射性氟化的通用方法。[18 F]氟化物，并通过开发与现有商业自动化放射性示踪剂合成平台无缝对接的化学品来促进该方法的一般使用。这种全新的能力将大大扩展PET可以成像的疾病类型，并将直接导致诊断成像和组织定位的创新协议。拟议的研究有三个具体目标。具体目标1是开发新的、通用的、高效的方法学，用于具有n.c.a.的官能化的富电子芳香族化合物的单步碘介导的放射性标记。[18F]氟化物。拟议的工作将建立在一个基础上的机理研究，描述了高产率形成芳基氟化物的二芳基碘鎓氟化物盐的还原消除。具体目标2是开发一种通用的合成方法，该方法允许将高度官能化的芳香族化合物直接转化为放射性示踪剂前体。具体目标3是通过提供与生物碱的晚期放射性相容的容易的保护基化学来扩大这种合成化学的范围。 公共卫生相关性：生物过程的非侵入性体内成像对于识别疾病状态和进展以及评估治疗方案的疗效至关重要。这项研究将解决新的正电子发射断层扫描（PET）成像剂的需要，通过开发一种新的方法，他们的合成。这项研究计划的成果将是新的诊断技术，以确定疾病状态和一个通用的和简单的手段，以获得各种各样的新的和现有的成像剂;这些化合物和程序将为医生提供新的机会来探测，诊断和评估人类疾病。

DESCRIPTION (provided by applicant): Noninvasive diagnostic imaging of tissues is essential for determining the identification and staging of diseases, and assessing the efficacy of treatment regimens. While most imaging methods provide structural information (CAT, X-Ray, MRI), positron emission tomography permits imaging of regions of specific biochemical activity. Positron emitting radiotracers may be designed to localize in specific tissue types, such as tumors, or they may give a measure of normal metabolic activity. The positron emitting nucleus 18F possesses an ideal half-life (110 minutes) and relatively short positron diffusion distance (1 mm); these features permit relatively high resolution images obtained from [18F]fluorinated radiotracers to be acquired rapidly, with little lingering radioactivity hazard for the patient. Unfortunately, preparation of many desirable [18F]fluoride-labeled radiotracers is stymied by the lack of highly efficient, broadly applicable aromatic radiofluorination methods. The goals of this research project are to develop general methodology to radiofluorinate electron rich aromatic rings with no-carrier-added (n.c.a.) [18F]fluoride and to facilitate general use of this methodology by developing chemistry that interfaces seamlessly with existing commercial automated radiotracer synthesis platforms. This wholly new capability will expand dramatically the types of diseases that can be imaged by PET, and will lead directly to innovative protocols for diagnostic imaging and tissue localization. The proposed research has three specific aims. Specific aim 1 is to develop new, general, highly efficient methodology for single-step iodine-mediated radiofluorination of functionalized, electron-rich aromatic compounds with n.c.a. [18F]fluoride. The proposed work will build on a foundation of mechanistic studies describing the high yield formation of aryl fluorides from the reductive elimination of diaryliodonium fluoride salts. Specific aim 2 is to develop a general synthetic methodology that permits highly functionalized aromatic compounds to be transformed into radiotracer precursors directly. Specific aim 3 is to expand the scope of this synthetic chemistry by providing facile protecting group chemistry that is compatible with late stage radiofluorination of alkaloids. PUBLIC HEALTH RELEVANCE: Noninvasive, in vivo imaging of biological processes is essential for identifying disease states and progression, and for assessing the efficacy of treatment regimens. This research will address the need for new positron emission tomography (PET) imaging agents by developing a novel methodology for their synthesis. The outcomes of this research program will be new diagnostic techniques to identify disease states and a general and facile means to access a wide variety of new and existing imaging agents; these compounds and procedures will provide the physician with new opportunities to probe, diagnose and assess human disorders.